NEWS
Larkem V40 wins a 2026 Australian Good Design Award for closed, automated vial filling in cell therapy manufacturing
Celleo’s Larkem V40 has been named a Winner in the Product Design (Medical and Scientific) category of the 2026 Australian Good Design Awards.
Celleo and CCRM Nordic present data on closed CAR-T vial filling at Advanced Therapies Europe
Celleo CEO David Kneen and Chao Sheng, Director of Process [...]
CGT Catapult evaluates closed vial filling for iPSC cell banking
Cell and Gene Therapy Catapult (CGT Catapult), an independent [...]
First Larkem® V40 customer delivery
Celleo’s first production Larkem® V40, with some of the [...]
Ministerial visit recognises facility manufacturing Celleo consumables
Hon. Colin Brooks visiting Celleo’s production line for Cell [...]
Board changes at Celleo guiding transition to global product deployment
Celleo is pleased to announce [...]
Celleo Ships First Larkem™ V40 System to Leading CAR-T Manufacturer
Celleo is proud to announce [...]
Celleo CEO David Kneen appointed to Cell and Gene Catalyst Expert Working Group
David Kneen, CEO of Celleo, [...]
Celleo Appoints Three Independent Non-Executive Directors
Celleo has appointed three experienced Non-Executive Directors to its Board. [...]
Celleo expands to new world-class facilities in Melbourne
Celleo has completed its relocation to new headquarters and laboratory [...]
Developing intelligent production systems for the manufacture of Cell and Gene Therapies
Celleo has begun emerging from the shadows of biotech stealth mode.
NEWS
Larkem V40 wins a 2026 Australian Good Design Award for closed, automated vial filling in cell therapy manufacturing
Celleo’s Larkem V40 has been named a Winner in the Product Design (Medical and Scientific) category of the 2026 Australian Good Design Awards.
Celleo and CCRM Nordic present data on closed CAR-T vial filling at Advanced Therapies Europe
Celleo CEO David Kneen and Chao Sheng, Director of Process [...]
CGT Catapult evaluates closed vial filling for iPSC cell banking
Cell and Gene Therapy Catapult (CGT Catapult), an independent [...]
First Larkem® V40 customer delivery
Celleo’s first production Larkem® V40, with some of the [...]
Ministerial visit recognises facility manufacturing Celleo consumables
Hon. Colin Brooks visiting Celleo’s production line for Cell [...]
Board changes at Celleo guiding transition to global product deployment
Celleo is pleased to announce [...]
Celleo Ships First Larkem™ V40 System to Leading CAR-T Manufacturer
Celleo is proud to announce [...]
Celleo CEO David Kneen appointed to Cell and Gene Catalyst Expert Working Group
David Kneen, CEO of Celleo, [...]
Celleo Appoints Three Independent Non-Executive Directors
Celleo has appointed three experienced Non-Executive Directors to its Board. [...]
Celleo expands to new world-class facilities in Melbourne
Celleo has completed its relocation to new headquarters and laboratory [...]
Developing intelligent production systems for the manufacture of Cell and Gene Therapies
Celleo has begun emerging from the shadows of biotech stealth mode.
